Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion type Assertion NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_head.
- NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_provenance.
- NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion evidence source_evidence_literature NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_provenance.
- NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion SIO_000772 16945414 NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_provenance.
- NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion wasDerivedFrom befree-2016 NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_provenance.
- NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion wasGeneratedBy ECO_0000203 NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_provenance.